CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.

Clinical trial NCT04697290 · SUSPENDED

Trial details

NCT number: NCT04697290
Sponsor: Beijing Tsinghua Chang Gung Hospital
Status: SUSPENDED
Phase: Early Phase 1
Study type: INTERVENTIONAL

B-cell Non-Hodgkin's Lymphoma

Start date: 2022-03-10
Primary completion: 2023-03-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.